Internal and Emergency Medicine

, Volume 9, Issue 5, pp 589–591 | Cite as

Is dual RAAS blockade useful in diabetic nephropathy?

  • Maddalena Alessandra Wu
  • Francesca Perego
  • Gruppo di Autoformazione Metodologica (GrAM)


Conflict of interest



  1. 1.
    American Diabetes Association (2013) Standards of medical care in diabetes 2013. Diabetes Care 36(Suppl 1):S11–S66. doi: 10.2337/dc13-S011 PubMedCentralCrossRefGoogle Scholar
  2. 2.
    Mann JF, Schmieder RE, McQueen M, Dyal L, Schumacher H, Pogue J, Wang X, Maggioni A, Budaj A, Chaithiraphan S, Dickstein K, Keltai M, Metsärinne K, Oto A, Parkhomenko A, Piegas LS, Svendsen TL, Teo KK, Yusuf S, ONTARGET investigators (2008) Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial. Lancet 372:547–553. doi: 10.1016/S0140-6736(08)61236-2 CrossRefPubMedGoogle Scholar
  3. 3.
    Parving HH, Brenner BM, McMurray JJ, de Zeeuw D, Haffner SM, Solomon SD, Chaturvedi N, Ghadanfar M, Weissbach N, Xiang Z, Armbrecht J, Pfeffer MA (2009) Aliskiren trial in type 2 diabetes using cardio-renal endpoints (ALTITUDE): rationale and study design. Nephrol Dial Transplant 24:1663–1671. doi: 10.1093/ndt/gfn721 CrossRefPubMedGoogle Scholar
  4. 4.
    Fried LF, Emanuele N, Zhang JH, Brophy M, Conner TA, Duckworth W, Leehey DJ, McCullough PA, O’Connor T, Palevsky PM, Reilly RF, Seliger SL, Warren SR, Watnick S, Peduzzi P, Guarino P, VA NEPHRON-D Investigators (2013) Combined angiotensin inhibition for the treatment of diabetic nephropathy. NEJM 369:1892–1903. doi: 10.1056/NEJMoa1303154 CrossRefPubMedGoogle Scholar

Copyright information

© SIMI 2014

Authors and Affiliations

  • Maddalena Alessandra Wu
    • 1
  • Francesca Perego
    • 1
  • Gruppo di Autoformazione Metodologica (GrAM)
    • 1
  1. 1.Division of Medicine, Department of Biomedical and Clinical Sciences “L. Sacco”, L. Sacco HospitalUniversity of MilanMilanItaly

Personalised recommendations